Genmedica Therapeutics

Genmedica Therapeutics is a biotechnology company in the development stage, focusing on type 2 diabetes. They believe that although there are many classes of oral medications that can effectively lower blood sugar, in reality, there is currently no ideal diabetes drug — drugs that not only lower blood sugar but also act as disease modifiers: slowing or halting the progression of the disease.Genmedica Therapeutics was founded in 2004 and is headquartered in Barcelona, Spain.